Home

plovoucí Přehled Vylučovat molecular markers injury tgf Aja Dříve Kůra

IJMS | Free Full-Text | Role of Transforming Growth Factor-β in Skeletal  Muscle Fibrosis: A Review
IJMS | Free Full-Text | Role of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review

Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision  Medicine | ACS Pharmacology & Translational Science
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine | ACS Pharmacology & Translational Science

Frontiers | TGF-β-Induced Endothelial to Mesenchymal Transition in Disease  and Tissue Engineering
Frontiers | TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity  and Sequelae | Journal of Interferon & Cytokine Research
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae | Journal of Interferon & Cytokine Research

TGF-β: the master regulator of fibrosis | Nature Reviews Nephrology
TGF-β: the master regulator of fibrosis | Nature Reviews Nephrology

Frontiers | The Roles of TGF-β Signaling in Cerebrovascular Diseases
Frontiers | The Roles of TGF-β Signaling in Cerebrovascular Diseases

Integrated analysis reveals the molecular features of fibrosis in  triple-negative breast cancer: Molecular Therapy - Oncolytics
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics

Biomedicines | Free Full-Text | Resveratrol Modulates Transforming Growth  Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight  into Its Pharmacological Activities
Biomedicines | Free Full-Text | Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities

Molecular pathways involved in injury-repair and ADPKD progression -  ScienceDirect
Molecular pathways involved in injury-repair and ADPKD progression - ScienceDirect

Gli2-regulated activation of hepatic stellate cells and liver fibrosis by  TGF-β signaling | American Journal of Physiology-Gastrointestinal and Liver  Physiology
Gli2-regulated activation of hepatic stellate cells and liver fibrosis by TGF-β signaling | American Journal of Physiology-Gastrointestinal and Liver Physiology

IJMS | Free Full-Text | TGF-β Signaling: From Tissue Fibrosis to Tumor  Microenvironment
IJMS | Free Full-Text | TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment

Frontiers | The Role of Macrophages in Kidney Fibrosis
Frontiers | The Role of Macrophages in Kidney Fibrosis

Endothelial Cell TGF-β (Transforming Growth Factor-Beta) Signaling  Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula  Patency | Arteriosclerosis, Thrombosis, and Vascular Biology
Endothelial Cell TGF-β (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency | Arteriosclerosis, Thrombosis, and Vascular Biology

Biomolecules | Free Full-Text | The Synergistic Cooperation between TGF-β  and Hypoxia in Cancer and Fibrosis
Biomolecules | Free Full-Text | The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis

Current potential therapeutic strategies targeting the TGF-β/Smad signaling  pathway to attenuate keloid and hypertrophic scar formation - ScienceDirect
Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation - ScienceDirect

Biomolecules | Free Full-Text | Role of TGF-Beta and Smad7 in Gut  Inflammation, Fibrosis and Cancer
Biomolecules | Free Full-Text | Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver  Fibrosis in Human Hepatic Stellate Cells | ACS Chemical Biology
Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells | ACS Chemical Biology

Biomolecules | Free Full-Text | Transforming Growth Factor-β Signaling in  Fibrotic Diseases and Cancer-Associated Fibroblasts
Biomolecules | Free Full-Text | Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

Frontiers | TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Frontiers | TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

TGF-β1 in plasma and cerebrospinal fluid can be used as a biological  indicator of chronic pain in patients with osteoarthritis | PLOS ONE
TGF-β1 in plasma and cerebrospinal fluid can be used as a biological indicator of chronic pain in patients with osteoarthritis | PLOS ONE

TGF-β signaling in vascular biology and dysfunction | Cell Research
TGF-β signaling in vascular biology and dysfunction | Cell Research

Transforming growth factor-β in stem cells and tissue homeostasis | Bone  Research
Transforming growth factor-β in stem cells and tissue homeostasis | Bone Research

Frontiers | Transforming Growth Factor-β-Induced Cell Plasticity in Liver  Fibrosis and Hepatocarcinogenesis
Frontiers | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis

TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts  | Scientific Reports
TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts | Scientific Reports

Biomedicines | Free Full-Text | TGF-β as a Key Modulator of Astrocyte  Reactivity: Disease Relevance and Therapeutic Implications
Biomedicines | Free Full-Text | TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications

Cells | Free Full-Text | TGF-β Superfamily Signaling in the Eye:  Implications for Ocular Pathologies
Cells | Free Full-Text | TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies

TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in  Modulating Corneal Allograft Immune Rejection In Vivo: Molecular Therapy
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo: Molecular Therapy